News | May 25, 2023
Mandaviya addresses 76th World Health Assembly
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Subscribe To Our Newsletter & Stay Updated
